AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vildawyn M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Wynclark Pharmaceuticals Private Limited

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildawyn M 500mg/50mg Tablet

Vildawyn M 500mg/50mg tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action mitigates the risk of severe diabetic complications, such as renal impairment and vision loss, and may lessen the likelihood of cardiovascular events. Vildawyn M 500mg/50mg tablets may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy is achieved when coupled with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glucose levels, and concomitant medications. Consuming the medication with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. This treatment helps regulate blood sugar, preventing future complications. Adherence to the prescribed diet and exercise plan is crucial for successful diabetes management; lifestyle choices are integral to overall control. Commonly reported adverse effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential side effect, particularly when used with insulin or sulfonylureas; patients should be educated on its recognition and management. This medication is not universally appropriate. Prior to initiating therapy, inform your physician of any history of renal, hepatic, or cardiac disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating women require medical consultation before use. Potential drug interactions necessitate disclosure of all current medications to ensure safety. Alcohol should be avoided due to its potential to induce hypoglycemia. Regular monitoring of kidney function and blood glucose levels will be conducted by your doctor throughout treatment.

Primary Ingredients of Vildawyn M 500mg/50mg Tablet

No text provided. Please provide the text you would like me to rephrase.

Uses of Vildawyn M 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Vildawyn M 500mg/50mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the Vildawyn M 500mg/50mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

Common Side effects of Vildawyn M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildawyn M 500mg/50mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Vildawyn M 500mg/50mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with food.

How Vildawyn M 500mg/50mg Tablet works:

Metformin and Vildagliptin 500mg/50mg tablets combine two distinct anti-diabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vildawyn M 500mg/50mg Tablet with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vildawyn M 500mg/50mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Vildawyn M 500mg/50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is a possibility if your blood glucose levels are abnormally low or elevated. Refrain from driving should these conditions arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vildawyn M 500mg/50mg tablets cautiously. Dosage modification for Vildawyn M 500mg/50mg tablets may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Use of Vildawyn M 500mg/50mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Physician consultation is recommended.

What if you forget to take Vildawyn M 500mg/50mg Tablet :

Should you forget to take your Vildawyn M 500mg/50mg Tablet, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vildawyn M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Vildawyn M 500mg/50mg Tablet

Vildawyn M 500mg/50mg Tablets rarely cause hypoglycemia by themselves. However, low blood sugar can result from inadequate calorie intake while using this medication. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness may occur. These are more likely if meals are missed or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildawyn M 500mg/50mg Tablets. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) warrant immediate medical attention. Do not take other medications without consulting your doctor.
Vildawyn M 500mg/50mg Tablets are contraindicated in patients with allergies to its components or excipients, and should not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Vildawyn M 500mg/50mg tablets combine metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vildawyn M 500mg/50mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoidance in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Vildawyn M 500mg/50mg Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia and neurological complications.
Vildawyn M 500mg/50mg Tablet is safe when used as directed by your doctor. However, even with correct usage, you may experience side effects such as nausea, diarrhea, vomiting, upset stomach, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if also taking insulin or sulphonylurea). Report any persistent issues to your doctor.
Vildawyn M 500mg/50mg Tab...
173
MRP 200
13% off